Technology
Health
Therapy

Neoleukin Therapeutics

394

$10.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell NLTX and other stocks, options, ETFs, and crypto commission-free!

About NLTX

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Read More Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA.

CEO
Jonathan G. Drachman
Employees
36
Headquarters
Seattle, Washington
Founded
2003
Market Cap
414.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
418.47K
High Today
$11.17
Low Today
$10.36
Open Price
$10.70
Volume
269.55K
52 Week High
$13.71
52 Week Low
$2.19

Collections

Technology
Health
Therapy
Biopharmaceutical
Medical
Pharmaceutical
2014 IPO
US

NLTX Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, After Hours

People Also Bought

Plug Power

256,391

$3.37

+1.81%

Plug Power

256,391

$3.37

+1.81%

Inovio

223,452

$7.45

-3.25%

Inpixon

29,986

$1.15

0.00%

Aurinia Pharmaceuticals

11,151

$14.36

+1.70%

You May Also Like

DGRE
SNCR
EDUC
LGF.B
ZLAB
DOG
KIM
EIDX
BOOT
BCX
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy NLTX

Market Price$10.80
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell NLTX stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up